Hims & Hers Health Inc. (NYSE:HIMS) experienced a 2.4% rise in its stock price during after-hours trading on Tuesday, following the announcement of insider buying by Director David B. Wells. According to a Form 4 filing with the Securities and Exchange Commission (SEC), Wells purchased 48,400 shares of Class A Common Stock on May 26, 2026, at an average weighted price of $24.235. The individual purchase prices varied between $24.19 and $24.25. This acquisition brings Wells' total holdings in the company to 224,417 shares. Insider buying typically signals confidence from company leadership regarding the stock's value and future performance, which can positively influence investor sentiment. The SEC filing complies with Section 16(a) of the Securities Exchange Act of 1934, which mandates that company insiders disclose their transactions in company securities. Such insider activity is closely monitored by investors as it may indicate the board's belief in the company's growth potential and overall market position.